LEADER 01107nam a22002651i 4500 001 991001183509707536 005 20031017080233.0 008 040407s1976 it |||||||||||||||||ita 035 $ab12731572-39ule_inst 035 $aARCHE-071121$9ExL 040 $aDip.to Scienze Storiche$bita$cA.t.i. Arché s.c.r.l. Pandora Sicilia s.r.l. 082 04$a973 100 1 $aColombo, Furio$0105821 245 12$aI prossimi americani :$bchi è chi nelle elezioni presidenziali USA del 1976 : intervista con tutti i protagonisti della vita politica americana /$cFurio Colombo 260 $aMilano :$bGarzanti,$c1976 300 $a234 p. ;$c21 cm 440 0$aMemorie e documenti 650 4$aElezioni politiche$zStati Uniti d'America$y1976 650 4$aUomini politici$zStati Uniti d'America$xBiografie 907 $a.b12731572$b02-04-14$c16-04-04 912 $a991001183509707536 945 $aLE009 STOR.898-99$g1$i2009000376007$lle009$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i13265921$z16-04-04 996 $aProssimi americani$9268262 997 $aUNISALENTO 998 $ale009$b16-04-04$cm$da $e-$fita$git $h2$i1 LEADER 01550nam0 22003251i 450 001 UON00379616 005 20231205104520.879 100 $a20100329d1966 |0itac50 ba 101 $aita 102 $aIT 105 $a|||| 1|||| 200 1 $aˆIl ‰Circolo linguistico di Praga$ele tesi del '29$fintroduzione di Emilio Garroni$gtraduzione di Sergio Pautasso 205 $aMilano : Silva$b1966 210 $a113 p.$a21 cm 215 $aTit. orig.: Melanges linguistiques dedies au premier Congres des philologues slaves. 410 1$1001UON00379907$12001 $aˆI ‰Quaderni di Sigma. 500 1$3UON00379898$aMelanges linguistiques dedies au premier Congres des philologues slaves.$943087 606 $aCIRCOLO LINGUISTICO DI PRAGA$3UONC075320$2FI 620 $aIT$dMilano$3UONL000005 676 $a410.01$cLinguistica. Filosofia e teoria$v21 702 1$aGarroni$bEmilio$3UONV127930 702 1$aPAUTASSO$bSergio$3UONV177548 710 02$aPrazsk linguistick krouzek$3UONV196294$0703893 712 $aSilva$3UONV258958$4650 801 $aIT$bSOL$c20250307$gRICA 912 $aUON00379616 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI IX PRA $eSI SFR9138 5 $sBuono 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI IX PRA bis $eSI SFR3269 7 bis $sBuono 996 $aMelanges linguistiques dedies au premier Congres des philologues slaves$943087 997 $aUNIOR LEADER 04458nam 2201117z- 450 001 9910557430503321 005 20210501 035 $a(CKB)5400000000043418 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68973 035 $a(oapen)doab68973 035 $a(EXLCZ)995400000000043418 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aPhysiological and Pathological Role of ROS: Benefits and Limitations of Antioxidant Treatment 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (236 p.) 311 08$a3-03936-282-8 311 08$a3-03936-283-6 330 $aROS were long considered one of the key players in tissue injury. Indeed, overproduction of ROS results in oxidative stress, a process leading to the development of many pathological conditions. For the treatment of these conditions, the use of antioxidants was proposed. Over time, it was shown that ROS at low concentrations act as signaling molecules, leading to the regulation of physiological functions. Moreover, several interventions that increase ROS generation activate stress-adaptive responses that extend the lifespan. It was also shown that excessive use of antioxidants can counter the beneficial effects of ROS. Currently, much progress has been made in understanding the role of ROS in human diseases and aging, as well as in the regulation of physiological functions, and in identifying the signaling pathways involved in ROS. However, much remains to be understood about the mutual interactions among signaling pathways underlying organisms' adaptive responses, their modifications (which occur during aging), and some disease states. The aim of this Special Issue is to underline the effects of ROS production and antioxidant treatment in living organisms, focusing on their impact on health, disease, and aging. 517 $aPhysiological and Pathological Role of ROS 606 $aBiology, life sciences$2bicssc 606 $aResearch & information: general$2bicssc 610 $aAMPK pathway 610 $aantioxidant supplementation 610 $aAP-1 610 $aapoptosis 610 $aartemisinin 610 $aatherosclerosis 610 $ac-FLIP 610 $acancer 610 $acancer therapy 610 $acardiomyocytes 610 $acardiotoxicity 610 $acardiovascular disease 610 $acavefish 610 $acell viability 610 $achromophobe RCC 610 $aclear cell RCC 610 $aCORM-2 610 $aCTCL 610 $aD-box 610 $aDNA damage 610 $aendoplasmic reticulum stress 610 $aendothelial dysfunction 610 $aevolution 610 $aexercise 610 $aglutathione (GSH) metabolism 610 $aH2O2 610 $ahippocampal neurons 610 $aHO-1 610 $ainsulin resistance 610 $alight 610 $amitochondria 610 $amitochondrial membrane potential 610 $an/a 610 $aNADPH oxidase 610 $aneurodegenerative disorders 610 $aNrf2 610 $aoxidative stress 610 $apapillary RCC 610 $aperoxiredoxins 610 $aPGC-1 610 $aprotein aggregation 610 $aproteinopathy 610 $areactive oxygen species 610 $areactive oxygen species (ROS) 610 $aredox 610 $aredox signaling 610 $aRenal cell carcinoma (RCC) 610 $aROS 610 $aROS scavengers 610 $asarcopenia 610 $aSH-SY5Y cells 610 $aSpalax 610 $asphingomyelin synthase 2 610 $atrimethylamine N-oxide 610 $atumorigenesis 610 $aUCPs 610 $aXIAP 610 $a?-catenin 615 7$aBiology, life sciences 615 7$aResearch & information: general 700 $aDi Meo$b Sergio$4edt$01314049 702 $aVenditti$b Paola$4edt 702 $aNapolitano$b Gaetana$4edt 702 $aDi Meo$b Sergio$4oth 702 $aVenditti$b Paola$4oth 702 $aNapolitano$b Gaetana$4oth 906 $aBOOK 912 $a9910557430503321 996 $aPhysiological and Pathological Role of ROS: Benefits and Limitations of Antioxidant Treatment$93031626 997 $aUNINA